vs
MFA FINANCIAL, INC.（MFA）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
RE/MAX Holdings, Inc.的季度营收约是MFA FINANCIAL, INC.的1.3倍（$71.1M vs $55.5M），MFA FINANCIAL, INC.同比增速更快（9.2% vs -1.8%），过去两年MFA FINANCIAL, INC.的营收复合增速更高（7.7% vs -4.7%）
MFA Financial是总部位于美国的房地产投资信托（REIT），核心业务为投资及管理住宅与商业抵押贷款支持证券、抵押贷款及其他不动产相关金融资产，面向美国本土机构和个人投资者，通过审慎的资产筛选与风控机制追求稳定的经风险调整后收益。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
MFA vs RMAX — 直观对比
营收规模更大
RMAX
是对方的1.3倍
$55.5M
营收增速更快
MFA
高出11.0%
-1.8%
两年增速更快
MFA
近两年复合增速
-4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.5M | $71.1M |
| 净利润 | — | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | 97.9% | 13.1% |
| 净利率 | — | 2.0% |
| 营收同比 | 9.2% | -1.8% |
| 净利润同比 | — | -75.2% |
| 每股收益（稀释后） | $0.43 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MFARMAX
| Q4 25 | $55.5M | $71.1M | ||
| Q3 25 | $56.8M | $73.2M | ||
| Q2 25 | $61.3M | $72.8M | ||
| Q1 25 | $57.5M | $74.5M | ||
| Q4 24 | $50.8M | $72.5M | ||
| Q3 24 | $50.6M | $78.5M | ||
| Q2 24 | $53.5M | $78.5M | ||
| Q1 24 | $47.8M | $78.3M |
净利润MFARMAX
| Q4 25 | — | $1.4M | ||
| Q3 25 | $48.1M | $4.0M | ||
| Q2 25 | $33.2M | $4.7M | ||
| Q1 25 | $41.2M | $-2.0M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | $48.2M | $966.0K | ||
| Q2 24 | $41.9M | $3.7M | ||
| Q1 24 | $23.2M | $-3.4M |
营业利润率MFARMAX
| Q4 25 | 97.9% | 13.1% | ||
| Q3 25 | 84.5% | 25.0% | ||
| Q2 25 | 54.5% | 19.3% | ||
| Q1 25 | 70.0% | 7.2% | ||
| Q4 24 | 6.8% | 5.9% | ||
| Q3 24 | 98.2% | 19.4% | ||
| Q2 24 | 79.1% | 20.6% | ||
| Q1 24 | 50.7% | 5.8% |
净利率MFARMAX
| Q4 25 | — | 2.0% | ||
| Q3 25 | 84.7% | 5.4% | ||
| Q2 25 | 54.2% | 6.4% | ||
| Q1 25 | 71.6% | -2.6% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 95.2% | 1.2% | ||
| Q2 24 | 78.4% | 4.7% | ||
| Q1 24 | 48.5% | -4.3% |
每股收益（稀释后）MFARMAX
| Q4 25 | $0.43 | — | ||
| Q3 25 | $0.35 | — | ||
| Q2 25 | $0.21 | — | ||
| Q1 25 | $0.31 | — | ||
| Q4 24 | $-0.01 | — | ||
| Q3 24 | $0.37 | — | ||
| Q2 24 | $0.32 | — | ||
| Q1 24 | $0.14 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $213.2M | $118.7M |
| 总债务越低越好 | — | $432.2M |
| 股东权益账面价值 | $1.8B | $452.4M |
| 总资产 | $13.0B | $582.5M |
| 负债/权益比越低杠杆越低 | — | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资MFARMAX
| Q4 25 | $213.2M | $118.7M | ||
| Q3 25 | $305.2M | $107.5M | ||
| Q2 25 | $275.7M | $94.3M | ||
| Q1 25 | $253.7M | $89.1M | ||
| Q4 24 | $338.9M | $96.6M | ||
| Q3 24 | $305.6M | $83.8M | ||
| Q2 24 | $289.4M | $66.1M | ||
| Q1 24 | $306.3M | $82.1M |
总债务MFARMAX
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
股东权益MFARMAX
| Q4 25 | $1.8B | $452.4M | ||
| Q3 25 | $1.8B | $448.1M | ||
| Q2 25 | $1.8B | $442.4M | ||
| Q1 25 | $1.8B | $433.5M | ||
| Q4 24 | $1.8B | $429.5M | ||
| Q3 24 | $1.9B | $423.1M | ||
| Q2 24 | $1.9B | $418.4M | ||
| Q1 24 | $1.9B | $412.0M |
总资产MFARMAX
| Q4 25 | $13.0B | $582.5M | ||
| Q3 25 | $12.1B | $582.2M | ||
| Q2 25 | $11.7B | $574.8M | ||
| Q1 25 | $11.5B | $571.4M | ||
| Q4 24 | $11.4B | $581.6M | ||
| Q3 24 | $11.2B | $578.6M | ||
| Q2 24 | $11.1B | $571.4M | ||
| Q1 24 | $10.9B | $566.7M |
负债/权益比MFARMAX
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $76.2M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | — | $33.5M |
| 自由现金流率自由现金流/营收 | — | 47.1% |
| 资本支出强度资本支出/营收 | — | 10.4% |
| 现金转化率经营现金流/净利润 | — | 28.39× |
| 过去12个月自由现金流最近4个季度 | — | $56.8M |
8季度趋势，按日历期对齐
经营现金流MFARMAX
| Q4 25 | $76.2M | $40.9M | ||
| Q3 25 | $14.7M | $17.7M | ||
| Q2 25 | $38.5M | $4.6M | ||
| Q1 25 | $-14.6M | $5.7M | ||
| Q4 24 | $200.1M | $59.7M | ||
| Q3 24 | $-11.3M | $17.6M | ||
| Q2 24 | $46.5M | $15.9M | ||
| Q1 24 | $53.5M | $9.4M |
自由现金流MFARMAX
| Q4 25 | — | $33.5M | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | — | $4.0M | ||
| Q4 24 | — | $53.0M | ||
| Q3 24 | — | $16.3M | ||
| Q2 24 | — | $14.0M | ||
| Q1 24 | — | $6.8M |
自由现金流率MFARMAX
| Q4 25 | — | 47.1% | ||
| Q3 25 | — | 22.4% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 73.2% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | 17.8% | ||
| Q1 24 | — | 8.6% |
资本支出强度MFARMAX
| Q4 25 | — | 10.4% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | 3.3% |
现金转化率MFARMAX
| Q4 25 | — | 28.39× | ||
| Q3 25 | 0.31× | 4.45× | ||
| Q2 25 | 1.16× | 0.97× | ||
| Q1 25 | -0.35× | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | -0.23× | 18.22× | ||
| Q2 24 | 1.11× | 4.29× | ||
| Q1 24 | 2.30× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MFA
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
